Myriad Genetics Inc. Q4 Profit Drops 10%

(RTTNews) - Myriad Genetics Inc. (MYGN) released earnings for fourth quarter that lost ground compared to the same period last year.

The company said its profit totaled $26.4 million, or $0.36 per share. This was down from $29.4 million, or $0.41 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.38 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 1.8% to $186.5 million. This was down from $189.9 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q4): $26.4 Mln. vs. $29.4 Mln. last year. -Earnings Decline (Y-o-Y): -10.2% -EPS (Q4): $0.36 vs. $0.41 last year. -EPS Decline (Y-o-Y): -12.2% -Analysts Estimate: $0.38 -Revenue (Q4): $186.5 Mln vs. $189.9 Mln last year. -Revenue Change (Y-o-Y): -1.8%

-Guidance: Next quarter EPS guidance: $0.25-$0.27 Next quarter revenue guidance: $168-$170 Mln